(Q39330850)
Statements
Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer (English)
Kristiaan Lenos
Anna M Grawenda
Kirsten Lodder
Amina F A S Teunisse
Emmanouela Repapi
Lukasz F Grochola
Frank Bartel
Peter Wuerl
Anne-Marie Cleton-Jansen
Gareth L Bond
Aart G Jochemsen